Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

477
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
477
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

705
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
705
Drug Therapy01:28

Drug Therapy

199
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
199
Depression: Overview01:18

Depression: Overview

678
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
678
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

367
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
367
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

747
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
747

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stratified Psychosocial Care in Assisted Reproductive Technologies: A Narrative Review and Conceptual Framework Across the IVF Pathway.

Journal of clinical medicine·2026
Same author

Clinical and Prognostic Relevance of Cycle Pattern Recognition in Bipolar Disorder: A Further Step Toward Personalised Treatment Pathways?

Current neuropharmacology·2026
Same author

Autistic Trait Profiles Across Mood and Psychotic Spectrum Disorders: A Transdiagnostic Outpatient Study.

Journal of clinical medicine·2026
Same author

Psychotic Features in Unipolar and Bipolar Depression: Commentary.

Acta psychiatrica Scandinavica·2026
Same author

The Confounder in Plain Sight: A Retrospective Pilot Analysis on the Impact of Comorbidity on C-Reactive Protein Utility for Differentiating Bacterial vs. Viral Infections.

Antibiotics (Basel, Switzerland)·2026
Same author

Ratio of rates of suicide attempts to suicides in the general population and in mood disorder patients.

Journal of psychiatric research·2026

Related Experiment Video

Updated: Dec 26, 2025

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.0K

Melancholia: does this ancient concept have contemporary utility?

Gabriele Sani1,2, Leonardo Tondo3,4,5, Juan Undurraga5,6,7

  • 1Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, Rome, Italy.

International Review of Psychiatry (Abingdon, England)
|March 17, 2020
PubMed
Summary

The concept of melancholia in major depressive episodes shows limited clinical utility for predicting illness or guiding treatment. Research indicates few differences between melancholic and non-melancholic depression, suggesting it’s a state-dependent type.

Keywords:
Bipolar disorderDSM-5major depressionmelancholiatreatment

More Related Videos

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
06:08

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

9.6K
Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
05:56

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine

Published on: October 27, 2023

1.6K

Related Experiment Videos

Last Updated: Dec 26, 2025

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.0K
Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
06:08

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

9.6K
Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine
05:56

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine

Published on: October 27, 2023

1.6K

Area of Science:

  • Psychiatry and Mental Health
  • Clinical Psychology
  • Neuroscience

Background:

  • Efforts to categorize depressive illness aim to improve prediction and treatment guidance.
  • The concept of melancholia, a severe depression subtype, has been proposed but lacks consistent modern research support.
  • Existing research shows inconsistent findings regarding the distinctiveness of melancholic versus non-melancholic depression.

Purpose of the Study:

  • To investigate the clinical utility of melancholia as a distinct subtype of major depressive episodes.
  • To compare clinical and demographic differences between melancholic and non-melancholic depression.
  • To evaluate treatment response differences in melancholic versus non-melancholic depression.

Main Methods:

  • Analysis of over 3200 patient-subjects with DSM-5 major depressive episodes, categorized by melancholic characteristics.
  • Systematic review of clinical trials comparing treatment responses in melancholic and non-melancholic subjects.
  • Comparison of clinical, demographic, and treatment response data between the two groups.

Main Results:

  • Melancholic features were present in 35.2% of patients, with minimal clinical and demographic differences compared to non-melancholic subjects.
  • A systematic review found little difference in antidepressant treatment response between melancholic and non-melancholic depression.
  • Psychomotor retardation emerged as a potential differentiating feature, though symptom overlap is significant.

Conclusions:

  • The concept of melancholia may have limited value for clinical prediction and treatment selection in major depressive episodes.
  • Melancholia appears to be a state-dependent depression type associated with severity, rather than a distinct syndrome.
  • Current DSM-5 classification as a depression specifier is appropriate, and melancholia warrants further biomedical research.